{"transactions":[{"id":731829,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:55:10.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":66350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":66350,"derivative":{"exercise_price":2.48,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":66350},"source":{"system":"sec-edgar","filing":"0001610717-26-000270","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000161071726000270/form4.xml","form_type":"4"}},{"id":1113096,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-12T23:30:24.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":105705,"source":{"system":"sec-edgar","filing":"0000905148-25-002134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000090514825002134/form4.xml","form_type":"4"}},{"id":1119914,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:27:46.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":35144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":35144,"derivative":{"exercise_price":1.5,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":35144},"source":{"system":"sec-edgar","filing":"0000905148-25-002034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514825002034/form4.xml","form_type":"4"}},{"id":1480385,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-13T22:28:42.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":30120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":64722,"source":{"system":"sec-edgar","filing":"0000905148-24-001721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000090514824001721/form4.xml","form_type":"4"}},{"id":1487114,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:19:07.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":45642,"derivative":{"exercise_price":1.25,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":45642},"source":{"system":"sec-edgar","filing":"0000905148-24-001687","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824001687/form4.xml","form_type":"4"}},{"id":1854092,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:06:45.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":34602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":34602,"source":{"system":"sec-edgar","filing":"0001610717-23-000157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000161071723000157/form4.xml","form_type":"4"}},{"id":1854091,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:06:45.000Z","date":"2023-06-13","kind":"gift","planned":false,"acquired":false,"shares":11273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 13, 2023, the reporting person transferred 11,273 shares of the Issuer's common stock to a family trust of which the reporting person is trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-23-000157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000161071723000157/form4.xml","form_type":"4"}},{"id":1857411,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T23:54:41.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":41533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on June 8, 2024, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":41533,"derivative":{"exercise_price":2.075,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":41533},"source":{"system":"sec-edgar","filing":"0001140361-23-029698","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123029698/form4.xml","form_type":"4"}},{"id":2229742,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:59.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":11273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":11273,"source":{"system":"sec-edgar","filing":"0001567619-22-012973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761922012973/doc1.xml","form_type":"4"}},{"id":2229741,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:59.000Z","date":"2022-06-14","kind":"gift","acquired":false,"shares":4796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2022, the reporting person transferred 4,796 shares of the Issuer's common stock to a family trust of which the reporting person is trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-012973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761922012973/doc1.xml","form_type":"4"}},{"id":2251621,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T23:40:54.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":23885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest on May 26, 2023, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":23885,"derivative":{"exercise_price":4.85,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":23885},"source":{"system":"sec-edgar","filing":"0001567619-22-011962","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000156761922011962/doc1.xml","form_type":"4"}},{"id":2355358,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:30:24.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":28019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest monthly over three years from the vesting commencement date of March 1, 2022, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control."}],"balance_after":28019,"derivative":{"exercise_price":6.89,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":28019},"source":{"system":"sec-edgar","filing":"0001140361-22-007684","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036122007684/form4.xml","form_type":"4"}},{"id":2434728,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-14T21:05:41.000Z","date":"2021-09-15","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction involved a gift of securities by the Reporting Person made on September 15, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by The Smith Family Trust."}],"balance_after":72501,"source":{"system":"sec-edgar","filing":"0001567619-22-001195","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761922001195/doc1.xml","form_type":"5"}},{"id":2663244,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:17:30.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date."}],"balance_after":4796,"source":{"system":"sec-edgar","filing":"0001567619-21-012322","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761921012322/doc1.xml","form_type":"4"}},{"id":2663243,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:17:30.000Z","date":"2021-06-15","kind":"gift","acquired":false,"shares":8952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 15, 2021, the reporting person transferred 8,952 shares of the Issuer's common stock to a family trust of which the reporting person is trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-21-012322","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761921012322/doc1.xml","form_type":"4"}},{"id":2745478,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-19T19:57:02.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":5.25,"underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-027423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027423/doc4.xml","form_type":"4"}},{"id":2745477,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-19T19:57:02.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":5.25,"underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-21-027423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027423/doc4.xml","form_type":"4"}},{"id":2745476,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-19T19:57:02.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":185000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":12.47,"underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-21-027423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027423/doc4.xml","form_type":"4"}},{"id":2745475,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-04-19T19:57:02.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":138947,"price":38,"value":5279986.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, each issued and outstanding share of common stock of the Company, par value $0.001 per share (\"Common Stock\"), was converted into the right to receive $38.00 per share (the \"Offer Price\") in cash, without interest, minus any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-027423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027423/doc4.xml","form_type":"4"}},{"id":2745474,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-04-19T19:57:02.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of performance-based restricted Common Stock (as defined below) granted to the reporting person on June 24, 2019 (the \"Performance Award\"). The performance conditions associated with the Performance Award have not yet occurred. Pursuant to the Merger Agreement (as defined below), immediately prior to the effective time of the Merger (as defined below), the Performance Award was deemed to have vested and each share of Common Stock underlying the Performance Award was converted into the right to receive the Offer Price (as defined below) in cash, without interest, minus any applicable withholding taxes."}],"balance_after":138947,"source":{"system":"sec-edgar","filing":"0001209191-21-027423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027423/doc4.xml","form_type":"4"}},{"id":2830072,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-02-26T14:31:53.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":5110,"price":25.71,"value":131378.1,"ownership":{"direct":true},"balance_after":72947,"source":{"system":"sec-edgar","filing":"0001209191-21-014641","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121014641/doc4.xml","form_type":"4"}},{"id":2944896,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Performance-Based Restricted Common Stock","published_at":"2020-12-15T12:09:33.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares subject to this grant vest upon achievement of certain performance conditions, as further described in the other footnotes to this report."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 50% of the shares subject to this award, which shares vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company was greater than or equal to $19.43."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of the shares subject to this award vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company was greater than or equal to $12.95, and the remaining 50% of the shares subject to this award vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company was greater than or equal to $19.43."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"50% of the shares subject to this award vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company was greater than or equal to $12.95, and the remaining 50% of the shares subject to this award vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company was greater than or equal to $19.43."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-20-063391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120063391/doc4.xml","form_type":"4"}},{"id":2944895,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-12-15T12:09:33.000Z","date":"2020-12-11","kind":"tax_withholding","acquired":false,"shares":11504,"price":16.14,"value":185674.56,"ownership":{"direct":true},"balance_after":78057,"source":{"system":"sec-edgar","filing":"0001209191-20-063391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120063391/doc4.xml","form_type":"4"}},{"id":2944894,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-12-15T12:09:33.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of performance-based restricted common stock granted to the reporting person on June 24, 2019. These shares vested on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of Five Prime Therapeutics, Inc. (the \"Company\") was greater than or equal to $19.43."}],"balance_after":89561,"source":{"system":"sec-edgar","filing":"0001209191-20-063391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120063391/doc4.xml","form_type":"4"}},{"id":2964433,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-11-30T14:49:21.000Z","date":"2020-11-26","kind":"tax_withholding","acquired":false,"shares":6920,"price":18.45,"value":127674.0,"ownership":{"direct":true},"balance_after":67561,"source":{"system":"sec-edgar","filing":"0001209191-20-060707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120060707/doc4.xml","form_type":"4"}},{"id":2981606,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Performance-Based Restricted Common Stock","published_at":"2020-11-13T12:29:32.000Z","date":"2020-11-11","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares subject to this grant vest upon achievement of certain performance conditions, as further described in the other footnotes to this\nreport."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 50% of the shares subject to this award, which shares vested on the date that the 30-calendar-day volume-weighted average closing\nprice of a share of common stock of the Company was greater than or equal to $12.95."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The remaining shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of\ncommon stock of the Company is greater than or equal to $19.43, subject to the reporting person's continued service to the Company through such date; provided that such shares shall automatically expire and be forfeited if such\nshares have not vested by December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The remaining shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of\ncommon stock of the Company is greater than or equal to $19.43, subject to the reporting person's continued service to the Company through such date; provided that such shares shall automatically expire and be forfeited if such\nshares have not vested by December 31, 2021."}],"balance_after":22000,"derivative":{"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-20-058241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120058241/doc4.xml","form_type":"4"}},{"id":2981605,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-11-13T12:29:32.000Z","date":"2020-11-11","kind":"tax_withholding","acquired":false,"shares":10908,"price":18,"value":196344.0,"ownership":{"direct":true},"balance_after":74481,"source":{"system":"sec-edgar","filing":"0001209191-20-058241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120058241/doc4.xml","form_type":"4"}},{"id":2981604,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-11-13T12:29:32.000Z","date":"2020-11-11","kind":"exercise","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of performance-based restricted common stock granted to the reporting person on June 24, 2019. These shares vested on\nthe date that the 30-calendar-day volume-weighted average closing price of a share of common stock of Five Prime Therapeutics, Inc. (the\n\"Company\") was greater than or equal to $12.95."}],"balance_after":85389,"source":{"system":"sec-edgar","filing":"0001209191-20-058241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120058241/doc4.xml","form_type":"4"}},{"id":3105231,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:13:39.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":8952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock. The shares vest on the earlier of June 16, 2021 or the date of the Issuer's 2021 annual meeting of stockholders."}],"balance_after":8952,"source":{"system":"sec-edgar","filing":"0001567619-20-012369","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761920012369/doc1.xml","form_type":"4"}},{"id":3105230,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:13:39.000Z","date":"2020-06-11","kind":"gift","acquired":false,"shares":4947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2020, the reporting person transferred 4,947 shares of the Issuer's common stock to a family\ntrust of which the reporting person is trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012369","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761920012369/doc1.xml","form_type":"4"}},{"id":3216108,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-11T18:32:45.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying the option vest at a rate of one forty-eighth (1/48) per month following February 24, 2020, provided the reporting person provides services to the Company through each such date."}],"balance_after":90000,"derivative":{"exercise_price":5.25,"expiration_date":"2030-02-23","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-018244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/doc4.xml","form_type":"4"}},{"id":3216107,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-11T18:32:45.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a retention equity incentive award consisting of options to purchase shares of the Company's common stock. One-fourth (1/4) of the shares underlying this option will vest on February 24, 2021, and the remainder of the shares underlying this option vest at a rate of one forty-eighth (1/48) per month thereafter, provided the reporting person provides services to the Company through each such date."}],"balance_after":90000,"derivative":{"exercise_price":5.25,"expiration_date":"2030-02-23","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-018244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/doc4.xml","form_type":"4"}},{"id":3216106,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-03-11T18:32:45.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 24, 2021, 2022 and 2023, provided the reporting person provides services to the Company through each such date."}],"balance_after":63389,"source":{"system":"sec-edgar","filing":"0001209191-20-018244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/doc4.xml","form_type":"4"}},{"id":3216105,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-03-11T18:32:45.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a retention equity incentive award consisting of shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 24, 2021, 2022 and 2023, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the \"Company\") through each such date."}],"balance_after":48389,"source":{"system":"sec-edgar","filing":"0001209191-20-018244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120018244/doc4.xml","form_type":"4"}},{"id":3357789,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-11-27T15:53:45.000Z","date":"2019-11-26","kind":"tax_withholding","acquired":false,"shares":6611,"price":3.77,"value":24923.47,"ownership":{"direct":true},"balance_after":33389,"source":{"system":"sec-edgar","filing":"0001209191-19-058314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919119058314/doc4.xml","form_type":"4"}},{"id":3478163,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Performance-Based Restricted Common Stock","published_at":"2019-06-26T16:25:09.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares will vest upon achievement of certain performance conditions, as further described in Footnote 2."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"(i) 50% of the shares subject to this award will vest on the date that\nthe 30-calendar-day volume-weighted average closing price of a share of common stock of Five Prime Therapeutics, Inc. (the \"Company\") is greater than or equal to $12.95, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2020; and (ii) 50% of the shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company is greater than or equal to $19.43, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2021; in each case, subject to the reporting person's continued service to the Company through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"(i) 50% of the shares subject to this award will vest on the date that\nthe 30-calendar-day volume-weighted average closing price of a share of common stock of Five Prime Therapeutics, Inc. (the \"Company\") is greater than or equal to $12.95, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2020; and (ii) 50% of the shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company is greater than or equal to $19.43, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2021; in each case, subject to the reporting person's continued service to the Company through each such date."}],"balance_after":44000,"derivative":{"underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001209191-19-039096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919119039096/doc4.xml","form_type":"4"}},{"id":3491103,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T20:13:36.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":4947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders."}],"balance_after":4947,"source":{"system":"sec-edgar","filing":"0001567619-19-013338","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000156761919013338/doc1.xml","form_type":"4"}},{"id":3751875,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-11-27T19:21:08.000Z","date":"2018-11-26","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One fourth (1/4) of the shares underlying this option will vest on November 26, 2019, and the remainder of the shares underlying this option will vest at a rate of one forty-eighth (1/48) per month thereafter, provided the reporting person provides services to the Company through each such date."}],"balance_after":185000,"derivative":{"exercise_price":12.47,"expiration_date":"2028-11-25","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-18-060062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919118060062/doc4.xml","form_type":"4"}},{"id":3751874,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-11-27T19:21:08.000Z","date":"2018-11-26","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of November 26, 2019, 2020 and 2021, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the \"Company\") through each such date."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-18-060062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919118060062/doc4.xml","form_type":"4"}},{"id":3896566,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-13T01:01:00.000Z","date":"2018-06-11","kind":"grant","acquired":true,"shares":5923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock. The shares vest on the earlier of June 11, 2019 or the date of the Issuer's 2019 annual meeting of stockholders."}],"balance_after":5923,"source":{"system":"sec-edgar","filing":"0001140361-18-028289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000114036118028289/doc1.xml","form_type":"4"}},{"id":3968335,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-05T17:11:19.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":6000,"price":10.3688,"value":62212.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.125 to $10.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by The Smith Family Trust."}],"balance_after":56679,"source":{"system":"sec-edgar","filing":"0001140361-18-017389","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000114036118017389/doc1.xml","form_type":"4"}},{"id":4278817,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":36755,"kind":"person","name":"Smith David V","position":1,"cik":"0001229447","reported_name":"Smith David V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-16T22:45:55.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":17894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock. The shares vest on the earlier of June 14, 2018 or the date of the Issuer's 2017 annual meeting of stockholders."}],"balance_after":62679,"source":{"system":"sec-edgar","filing":"0001140361-17-025416","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229447/000114036117025416/doc1.xml","form_type":"4"}}]}